COVID-19 Vaccine: Zydus Cadila, Bharat Biotech in Phase II trial Ruchika Sharma17 Sept 2020 10:00 AM ISTNew Delhi: Indian Council of Medical Research (ICMR) Director General Balaram Bhargava said on Tuesday that Bharat Biotech and Zydus Cadilla are doing...
Aurobindo Pharma, CSIR join hands to develop COVID-19 vaccine Ruchika Sharma16 Sept 2020 11:37 AM ISTThree CSIR Labs namely CCMB Hyderabad, Institute of Medical Technology(IMTECH), Chandigarh and Indian Institute of Chemical Biology(IICB), Kolkata are...
Phase 1 trials of 2 indigenous COVID Vaccines reveal excellent safety: Minister Ruchika Sharma16 Sept 2020 11:00 AM ISTNew Delhi: Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in...
Pfizer, BioNTech eye expansion of COVID-19 vaccine trial to 44000 volunteers Ruchika Sharma15 Sept 2020 11:00 AM ISTNew York & Mainz, Germany: Pfizer Inc. and BioNTech SE have recently announced that they have submitted an amended protocol to the U.S....
AstraZeneca COVID-19 vaccine trial pause applauded by WHO Ruchika Sharma15 Sept 2020 9:30 AM ISTGeneva: A World Health Organization official on Tuesday said that the decision by AstraZeneca to pause global trials of its experimental coronavirus...
COVID-19 vaccine likely to be available by early 2021, will take first shot if any trust deficit: Dr Harsh Vardhan MD Bureau14 Sept 2020 2:00 PM ISTHe assured the vaccine would be first made available to those who need it the most, irrespective of their paying capacity.
Potential COVID vaccine: NII study conducted on mice show positive results Ruchika Sharma13 Sept 2020 9:30 AM ISTNew Delhi: An immunogenicity study conducted on mice for the coronavirus vaccine candidate being developed by the National Institute of...
COVID-19: Hindustan Syringes ramps up production to meet surged demand Ruchika Sharma11 Sept 2020 1:52 PM ISTHindustan Syringes said it is increasing its output of auto-disable devices(which prevent re-use) from 700 million a year to one billion by 2021 to...
AstraZeneca still aiming for Oxford COVID vaccine by 2020 end, says CEO Ruchika Sharma11 Sept 2020 1:04 PM ISTThe trial was halted after a person in the UK who was participating in it got sick, triggering a review of safety data.
Serum Institute halts COVID vaccine trials in India MD Bureau11 Sept 2020 10:00 AM ISTIn a statement, the Serum Institute of India said: "We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We...
Urgently reviewing AstraZeneca COVID-19 vaccine trial data, says Britain medical regulator Ruchika Sharma11 Sept 2020 8:45 AM ISTUK: Britain's medical regulator said on Wednesday it is urgently reviewing information available to determine whether AstraZeneca AZN.L can restart...
COVID-19: Pharma firms sign vaccine safety pledge MD Bureau9 Sept 2020 1:45 PM ISTThe CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer and Sanofi have signed the pledge.
